Regenxbio RGNX
NASDAQ RGNX
$7.56 +0.11 (+1.48%)
As of: Sep 30, 2026 · 10:25 AM EDT

Regenxbio (RGNX) Current Taxes (2018 - 2022)

Updated

Regenxbio's Current Taxes came in at $12.67 million for Q1 2022, up 216.4% from $4.01 million a year earlier and up 11.9% from the prior quarter.

Analysis

Regenxbio (RGNX) Current Taxes (2018 - 2022) Analysis & Trends

At the end of FY2021, Regenxbio's Current Taxes was $11.33 million, up 261.2% from FY2020.

  • Current Taxes carries a three-year compound annual growth rate of 149.9% (FY2018 to FY2021).
  • Going back by year, Current Taxes was $3.14 million in FY2020 and $726,000 in FY2018.
  • The Q1 2022 figure represents the highest quarterly Current Taxes in data going back to Q2 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 4.22 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 2.31 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -1.47 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 653.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Regenxbio 404.61 Mn -528.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 12.67 Mn
Dec 31, 2021 11.33 Mn
Mar 31, 2021 4.01 Mn
Dec 31, 2020 3.14 Mn
Sep 30, 2019 508,000.00
Jun 30, 2019 564,000.00
Mar 31, 2019 1.13 Mn
Dec 31, 2018 726,000.00
Sep 30, 2018 1.14 Mn
Jun 30, 2018 2.44 Mn
API Access

Regenxbio Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=RGNX&period=max&api_key=YOUR_API_KEY